Publications

cemka > Publications

Classer les publications sur l'année

  • Économie de la santĂ©

    Etude pharmaco-économique sur la prise en charge du reflux gastro-oesophagien en France en 2005 en médecine générale

    MOULY S, CHARLEMAGNE A, LE JEUNNE PH, FAGNANI F

    Presse Med ; 37:1397-1406

  • Pharmaco-EpidĂ©miologie

    Cutaneous Infrared Thermometry for Detecting Febrile Patients

    HAUSFATER P, ZHAO Y, DEFRENNE S, BONNET P, RIOU B

    Emerg Infect Dis ; 14(8):1255-1258

  • Économie de la santĂ©

    Costs and persistence of carbonic anhydrase inhibitor versus alpha2 agonists, associated with beta-blockers, in glaucoma an ocular hypertension : an analysis of the UKGPRD database

    LAFUMA A, BERDEAUX G

    Curr Med Res Opin ; 24(5):1519-1527

  • Économie de la santĂ©

    Costs and persistence of brimonidine versus brinzolamide in everyday glaucoma care : an analysis conducted on the UK General Practitioner Research Database

    LAFUMA A, LAURENDEAU C, BERDEAUX G

    J Med Econ ; 11(3):485-497

  • Économie de la santĂ©

    Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by the United Kingdom General Practitioner Research Database

    DENIS P, LAFUMA A, BERDEAUX G

    Clin Ophtalmol ; 2(2):321-329

  • Économie de la santĂ©

    Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients : A French adaptation of CARDS

    LAFUMA A, COLIN X, SOLESSE A

    Arch Cardiovasc Dis ; 2008;101(5):327-332

  • Économie de la santĂ©

    Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France

    STANDAERT B, PAREZ N, TEHARD B, COLIN X, DETOURNAY B

    Appl Health Econ Health Policy ; 6(4):199-216

  • Économie de la santĂ©

    Aspects Ă©pidĂ©miologiques et Ă©conomiques de l’insulinothĂ©rapie en Fance mĂ©tropolitaine

    DETOURNAY B

    Med Mal Metab ; (2):149-152

  • Pharmaco-EpidĂ©miologie

    A european survey of patient satisfaction with spectacles after cataract surgery and the associated costs in four European countries (France, Germany, Spain and Italy)

    CUQ C, LAFUMA A, JEANBAT V, BERDEAUX G

    Ophthalmic Epidemiol ; 15:234-241

  • Pharmaco-EpidĂ©miologie

    Vasodilators and Nootropics as Predictors of Dementia and Mortality in the PAQUID Cohort

    DARTIGUES JF, CARCAILLON L, HELMER C, LECHEVALLIER N, LAFUMA A, KHOSHNOOD B

    J Am Geriatr Soc ; 55:395-399

  • SantĂ© publique

    Un outil de suivi et d’auto-Ă©valuation du bon usage du mĂ©dicament en cancĂ©rologie : l’observatoire du mĂ©dicament d la FNCLCC

    LATOUR JF, GAMEROFF S, GENEVE J, FAGNANI F

    J Pharm Clin ; 26(3):151-157

  • Pharmaco-EpidĂ©miologie

    Self-reported visual impairment and mortality: a French nationwide perspective

    BERDEAUX G, BREZIN AP, FAGNANI F, LAFUMA A, MESBAH M

    Ophthalmic Epidemiol ; 14(2):80-87

  • SantĂ© publique

    Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity

    BANDELLO F, LAFUMA A, BERDEAUX G

    Invest Ophtalmol Vis Sci ; 48(1):86-103

  • SantĂ© publique

    Prise en charge du diabĂšte en France : des progrĂšs certains

    VARROUD-VIAL M, GUERCI B, ATTALI C, SIMON D, DETOURNAY B, HALIMI S, BOUEE S, BRAMI G, FAGOT-CAMPAGNA A, NACHIT-OUINEKH F, ESCHWEGE E, CHARBONNEL B, GRIMALDI A

    RĂ©seaux DiabĂšte ; (31):4-9

  • SantĂ© publique

    PrĂ©valence et coĂ»t du diabĂšte en France : oĂč en est-on?

    DETOURNAY B, BRAMI G, NACHIT-OUINEKH F, ESCHWEGE E

    MĂ©decine des Maladies MĂ©taboliques ; 1(2):1-4